Advanced search
Publication Cover
Clinical Interventions in Aging Volume 14, 2019 - Issue
Submit an article Journal homepage
95
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Electrocardiographic left ventricular hypertrophy and mortality in an oldest-old hypertensive Chinese population

Rui Chen1 Renal Division, Department of Medicine, Peking University First Hospital, Beijing, People’s Republic of China
,
Kunhao Bai2 Department of Endoscopy, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China
,
Fanghong Lu3 Cardio-Cerebrovascular Control and Research Center, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of China
,
Yingxin Zhao3 Cardio-Cerebrovascular Control and Research Center, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of China
,
Yujing Pan4 Renal Division, Department of Medicine, Peking University International Hospital, Beijing, People’s Republic of China
,
Fang Wang1 Renal Division, Department of Medicine, Peking University First Hospital, Beijing, People’s Republic of China
&
Luxia Zhang1 Renal Division, Department of Medicine, Peking University First Hospital, Beijing, People’s Republic of China;5 National Institute of Health Data Science at Peking University, Beijing, People’s Republic of China;6 Center for Data Science in Health and Medicine, Peking University, Beijing, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 1657-1662 | Published online: 17 Sep 2019

References

  • Beard JR, Officer A, de Carvalho IA, et al. The world report on ageing and health: a policy framework for healthy ageing. Lancet. 2016;387(10033):2145–2154. doi:10.1016/S0140-6736(15)00516-426520231
  • Dang JW, Wang YY, Liu NN. The Fourth Survey Report on the Living Conditions of China’s Urban and rural Older Persons; 2018.
  • Li HZ, Yang X, Zhu Y, et al. The general research report of chinese strategic for dealing with population aging. Sci Res Aging. 2015;3(3):4–35.
  • China NHaFPCo. China Health Statistics Yearbook 2013. National Health and Family Planning Commission of the People’s Republic of China; 2014.
  • Kannel WB. Potency of vascular risk factors as the basis for antihypertensive therapy. Eur Heart J. 1992;13:34–42. doi:10.1093/eurheartj/13.suppl_g.34
  • Jissho S, Shimada K, Taguchi H, et al. Impact of electrocardiographic left ventricular hypertrophy on the occurrence of cardiovascular events in elderly hypertensive patients. Circ J. 2010;74(5):938–945. doi:10.1253/circj.cj-09-072220339195
  • Okin PM, Hille DA, Kjeldsen SE, Devereux RB. Combining ECG criteria for left ventricular hypertrophy improves risk prediction in patients with hypertension. J Am Heart Assoc. 2017;6:11. doi:10.1161/JAHA.117.007564
  • Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322(22):1561–1566. doi:10.1056/NEJM1990053132222032139921
  • Brown DW, Giles WH, Croft JB. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J. 2000;140(6):848–856. doi:10.1067/mhj.2000.11111211099987
  • Antikainen RL, Peters R, Beckett NS, et al. Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: hypertension in the very elderly trial. J Hypertens. 2016;34(11):2280–2286. doi:10.1097/HJH.000000000000107327552643
  • Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–1898. doi:10.1056/NEJMoa080136918378519
  • Bai K, Pan Y, Lu F, Zhao Y, Wang J, Zhang L. Kidney function and cognitive decline in an oldest-old Chinese population. Clin Interv Aging. 2017;12:1049–1054. doi:10.2147/CIA.S13420528740370
  • Bulpitt C, Fletcher A, Beckett N, et al. Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial. Drugs Aging. 2001;18(3):151–164. doi:10.2165/00002512-200118030-0000111302283
  • Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–2944. doi:10.1681/ASN.200604036816988059
  • Havranek EP, Froshaug DB, Emserman CD, et al. Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity. Am J Med. 2008;121(10):870–875. doi:10.1016/j.amjmed.2008.05.03418823858
  • Bang CN, Soliman EZ, Simpson LM, et al. Electrocardiographic left ventricular hypertrophy predicts cardiovascular morbidity and mortality in hypertensive patients: the ALLHAT study. Am J Hypertens. 2017;30(9):914–922.28430947
  • Shenasa M, Shenasa H. Hypertension, left ventricular hypertrophy, and sudden cardiac death. Int J Cardiol. 2017;237:60–63. doi:10.1016/j.ijcard.2017.03.00228285801
  • Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016;354:i4482. doi:10.1136/bmj.i448227599725
  • Strauss DG. Differentiation between left bundle branch block and left ventricular hypertrophy: Implications for cardiac resynchronization therapy. J Electrocardiol 2012;45(6):635–9.23022304
  • Smiseth OA, Aalen JM. Mechanism of harm from left bundle branch block. Trends Cardiovasc Med. 2019;29(6):335-342. doi:10.1016/j.tcm.2018.10.012

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.